RPS DIAGNOSTICS - INFLAMMADRY AND ADENOPLUS DIAGNOSTIC BUSINESSES
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses are rapid, lateral-flow based, POC products for the detection of infectious and inflammatory diseases and conditions of the eye. InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory marker for dry eye. AdenoPlus is a test on market today that differentiates between a viral and bacterial infection of acute conjunctivitis (pink eye). Both products utilize innovative patented technology, are also CE marked, FDA-cleared, CLIA-waived, and complement Quidel's existing rapid diagnostic testing solutions. Manufacturing for both products will be transferred to Quidel's San Diego facility in the near term.
RPS DIAGNOSTICS - INFLAMMADRY AND ADENOPLUS DIAGNOSTIC BUSINESSES
Industry:
Biotechnology Health Care Manufacturing
Founded:
2004-01-01
Address:
Sarasota, Florida, United States
Country:
United States
Status:
Active
Similar Organizations
Redox Diagnostics
Redox Diagnostics is a company that uses diagnostic tests to search for Alzheimers Disease in patients.
More informations about "RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses"
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses are rapid, lateral-flow based, POC products for the detection of infectious and inflammatory diseases and conditions …See details»
Quidel Completes Acquisition of InflammaDry(R) and …
May 16, 2017 · InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory marker for dry eye. AdenoPlus is a test on market today that differentiates …See details»
Quidel acquires RPS Diagnostics' eye-health businesses for $14M
May 16, 2017 · Quidel Corp. completed the acquisition of the InflammaDry and AdenoPlus diagnostic businesses from RPS Diagnostics for about $14 million in cash. The InflammaDry …See details»
Quidel Completes Acquisition of InflammaDry(R) and …
May 16, 2017 · InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory marker for dry eye. AdenoPlus is a test on market today that differentiates …See details»
Quidel completes acquisition of InflammaDry and AdenoPlus eye …
SAN DIEGO, CA--(Marketwired - May 16, 2017) - Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular …See details»
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses
Explore RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses with its drug pipeline, therapeutic area, technology platform, . Biomedical products DataSee details»
Quidel Closes $14M Acquisition of POC Eye Health …
May 17, 2017 · NEW YORK (360Dx) – Quidel announced on Tuesday it has completed the acquisition of the InflammaDry and AdenoPlus diagnostic businesses from point-of-care eye health diagnostics manufacturer RPS …See details»
Quidel Corporation acquired InflammaDry (R) and AdenoPlus (R) …
May 15, 2017 · Quidel Corporation (NasdaqGS:QDEL) acquired InflammaDry (R) and AdenoPlus (R) Eye-Health Businesses from RPS Diagnostics, Inc. for $14 million on May 16, 2017. …See details»
RPS Diagnostics - InflammaDry and AdenoPlus diagnostic …
May 16, 2017 · Acquired Organization: RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses RPS Diagnostics - InflammaDry and AdenoPlus diagnostic businesses are rapid, …See details»
Quidel Acquires RPS’ InflammaDry, AdenoPlus Ophthalmic …
Quidel Corporation has completed its acquisition of the InflammaDry and AdenoPlus diagnostic businesses from RPS Diagnostics for approximately $14 million, Q...See details»
Interview with Doug Devries, OD on the Diagnosis of Inflammatory …
May 5, 2023 · QuidelOrtho’s point-of-care eye health solutions include InflammaDry® and the QuickVue® Adenoviral conjunctivitis Test. Both are rapid, lateral-flow based, point-of-care …See details»
Quidel Completes Acquisition of InflammaDry(R) and
May 16, 2017 · InflammaDry is the only test that detects elevated levels of MMP-9, a key inflammatory marker for dry eye. AdenoPlus is a test on market today that differentiates …See details»
In-office lab testing provides diagnostic information - Optometry …
May 19, 2017 · These tests include InflammaDry to detect elevated levels of MMP-9, a nonspecific inflammatory marker that has consistently been shown to be elevated in the tears …See details»
InflammaDry® MMP-9 Test - QuidelOrtho
InflammaDry MMP-9 is an easy-to-perform, disposable and low-cost test that utilizes direct sampling microfiltration technology, providing a two-color result that is simple to read and …See details»
Quidel’s InflammaDry ® Point-of-Care Testing for Dry Eye: …
Apr 29, 2022 · InflammaDry ® is the first rapid, in-office, CLIA-waived test that detects elevated levels of MMP-9, an inflammatory marker that is consistently elevated in the tears of patients …See details»
RPS Office Dry-Eye Test Cleared by FDA - Review of Ophthalmology
Feb 10, 2014 · Rapid Pathogen Screening announced that the Food and Drug Administration has cleared InflammaDry, a rapid, disposable, in-office test to aid in the diagnosis of dry-eye …See details»
Quidel Completes Acquisition of InflammaDry(R) and …
May 16, 2017 · Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announcedSee details»
Point-of-care testing helps dry eye diagnosis - Optometry Times
Feb 17, 2021 · Several studies have evaluated the sensitivity and specificity of InflammaDry in the diagnosis of dry eye disease using various metrics and inclusion criteria, such as Schirmer …See details»
RPS Diagnostics obtains CE mark approval for FebriDx test
Oct 9, 2014 · RPS also provides AdenoPlus test, which helps in the diagnosis of Adenoviral conjunctivitis (pink eye), and InflammaDry test that allows in the diagnosis of dry eye disease.See details»
AdenoPlus test effective for in-office adenoviral conjunctivitis ...
Apr 8, 2013 · This prospective masked study found that the AdenoPlus test is sensitive and specific at detecting adenoviral conjunctivitis. A second-generation Rapid Pathogen …See details»